In May of this year, Fast Company reported employees at the mushroom coffee brand MUD\WTR added small amounts of hallucinogenic (psilocybin) mushrooms to their morning brew. Silicon Valley employees have long been rumoured to microdose psychedelics at work to enhance focus, creativity, and improve productivity. The popularity of microdosing has since grown among politicians and …
Novel Nasal-Spray Nano-Formulation Enables Nose-To-Brain Delivery of Biodegradable Nanoparticles that can Encapsulate Psychedelic Substances such as Psilocybin Madrigal Mental Care, a biopharmaceutical company developing a breakthrough delivery system for psychedelic drugs, introduced its novel nanotechnology for the treatment and prevention of post-traumatic stress disorder (PTSD) at Biomed Israel 2022, the premier international Life Science and …
Psychedelic drugs, like psilocybin, an ingredient found in so-called magic mushrooms, have shown promise in treating a range of addictions and mental health disorders. Yet, there’s something mysterious and almost mystical about their effects, and they are commonly believed to provide unique insights into the nature of consciousness. Now, a new study by Johns Hopkins …
New Study Explores Relationship Between Psychedelics and Consciousness Read More »
By Raley Anne James Psychedelic substances have potential for treating physical pain, especially for seniors suffering from chronic pain. However, such potential has long been held back by the strict anti-drug laws that have lumped medically useful substances like psilocybin and cannabis alongside legitimately harmful narcotics such as cocaine and heroin. Fortunately, as discussed in a …
By Raley Anne James According to a mental health organization, one in five adults in the U.S. experience having a mental illness each year. These include serious mental health conditions such as anxiety disorders, major depressive episodes, and post-traumatic stress disorder. Despite the various organizations trying to counter these issues to increase mental health awareness and …
Using Psychoactive Plants and Fungi for Long-Term Mental Wellness Read More »
A global team of researchers have launched a first-of-its-kind research institute that will develop psychedelic medicines to treat mental health disorders and other medical conditions. The network is headquartered in Melbourne, Australia, and is supported with a planned investment of at least A$40 million dollars over five years. The newly launched Psychae Institute is the world’s first collaborative …
World’s First Global Research Institute for Psychedelic Therapies Opens Its Doors Read More »
The Project on Psychedelics Law and Regulation Seeks to Advance Evidence-Based Psychedelics Law and Policy The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School has announced a new research initiative, the Project on Psychedelics Law and Regulation (POPLAR). This three-year project will promote safety, innovation, and equity in psychedelics research, commerce, and …
Harvard Law’s Petrie-Flom Center Announces Project on Psychedelics Law and Regulation Read More »
UNLV Neuroscientists’ Work on Brain Activity Recently Published by Nature: Scientific Reports Psychedelic healing may sound like a fad from the Woodstock era, but it’s a field of study that’s gaining traction in the medical community as an effective treatment option for a growing number of mental health conditions. While the study of psychedelics as medicine …
Psychedelic Science Holds Promise for Mainstream Medicine Read More »
ATMA and SYNTAC Institute Collaborate to Submit a Group Application for Section 56 Exemption from Health Canada to Access Psychedelic Therapy ATMA Journey Centers Inc. (ATMA), an Alberta-based company focused on delivering innovative psychedelic-assisted therapies internationally, announced today that it has submitted a Group Application for Section 56 Exemption to Health Canada on behalf of Canadians …
In a small study of adults with major depression, Johns Hopkins Medicine researchers report that two doses of the psychedelic substance psilocybin, given with supportive psychotherapy, produced rapid and large reductions in depressive symptoms, with most participants showing improvement and half of study participants achieving remission through the four-week follow-up. A compound found in so-called …
Study Shows Psychedelic Treatment with Psilocybin Relieves Major Depression Read More »
